Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oreofe O Odejide

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
JAMA|January 20, 2016
A Policy Prescription for Hospice CareOreofe O Odejide
Hematology. American Society of Hematology. Education Program|December 4, 2020
Strategies for introducing palliative care in the management of relapsed or refractory aggressive lymphomasOreofe O Odejide
The Oncologist|July 24, 2023
Access to High-Quality Hospice Care in a For-Profit WorldOreofe O Odejide, Melissa D Aldridge
Hematology. American Society of Hematology. Education Program|December 9, 2022
Sequencing therapy in relapsed DLBCLChristopher R Flowers, Oreofe O Odejide
The Lancet. Haematology|May 4, 2020
Patients with haematological malignancies should not have to choose between transfusions and hospice careOreofe O Odejide, David P Steensma
Current Hematologic Malignancy Reports|April 17, 2021
Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies-Are We Close?Thomas M Kuczmarski, Oreofe O Odejide
Blood|January 15, 2026
Patient-reported outcomes: a Polaris for POLARIXOreofe O Odejide, Gregory A Abel
Blood Reviews|February 24, 2024
Depression in patients with hematologic malignancies: The current landscape and future directionsThomas M Kuczmarski, Lizabeth Roemer, Oreofe O Odejide
Cancer|February 1, 2014
Reply to quality control of bone marrow aspirates: additional steps toward a safer and more efficient procedureOreofe O Odejide, Joseph O Jacobson, Gregory A Abel
Anticancer Research|May 18, 2012
Survival of a patient with anaplastic thyroid cancer following intensity-modulated radiotherapy and sunitinib--a case reportJonathan D Schoenfeld, Oreofe O Odejide, Lori J Wirth, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
JAMA|January 20, 2016
A Policy Prescription for Hospice CareOreofe O Odejide
Hematology. American Society of Hematology. Education Program|December 4, 2020
Strategies for introducing palliative care in the management of relapsed or refractory aggressive lymphomasOreofe O Odejide
The Oncologist|July 24, 2023
Access to High-Quality Hospice Care in a For-Profit WorldOreofe O Odejide, Melissa D Aldridge
Hematology. American Society of Hematology. Education Program|December 9, 2022
Sequencing therapy in relapsed DLBCLChristopher R Flowers, Oreofe O Odejide
The Lancet. Haematology|May 4, 2020
Patients with haematological malignancies should not have to choose between transfusions and hospice careOreofe O Odejide, David P Steensma
Current Hematologic Malignancy Reports|April 17, 2021
Goal of a "Good Death" in End-of-Life Care for Patients with Hematologic Malignancies-Are We Close?Thomas M Kuczmarski, Oreofe O Odejide
Blood|January 15, 2026
Patient-reported outcomes: a Polaris for POLARIXOreofe O Odejide, Gregory A Abel
Blood Reviews|February 24, 2024
Depression in patients with hematologic malignancies: The current landscape and future directionsThomas M Kuczmarski, Lizabeth Roemer, Oreofe O Odejide
Cancer|February 1, 2014
Reply to quality control of bone marrow aspirates: additional steps toward a safer and more efficient procedureOreofe O Odejide, Joseph O Jacobson, Gregory A Abel
Anticancer Research|May 18, 2012
Survival of a patient with anaplastic thyroid cancer following intensity-modulated radiotherapy and sunitinib--a case reportJonathan D Schoenfeld, Oreofe O Odejide, Lori J Wirth, et al.
Pageof 6